This white paper provides biotech companies an overview of the considerations for Chemistry, Manufacturing and Controls (CMC) in asset development. There are a multitude of complexities and points to consider when... Read more »
Sponsored · Whitepaper
This white paper provides biotech companies an overview of the considerations for Chemistry, Manufacturing and Controls (CMC) in asset development. There are a multitude of complexities and points to consider when... Read more »
Sponsored · Whitepaper
A decentralized clinical trials model is especially important for patients with rare, genetic, or complex diseases. Learn how this model increases access to trials, bringing new therapies to rare disease patients... Read more »
Sponsored · Whitepaper
Learn how small biotech companies can navigate the complexities of asset development and selecting a drug development partner
Emerging biotech companies are a significant and burgeoning sector of... Read more »
Sponsored · Whitepaper
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
The current drug development research paradigm is flawed... Read more »
Sponsored · Webinar
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
The high mortality rate in COVID-19 patients has been linked to cytokine release syndrome,... Read more »
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Drug-induced QT interval prolongation and Torsades de Pointes (TdP) arrhythmias are the leading... Read more »
Sponsored · Whitepaper
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
Pharmaceutical manufacturers invest countless resources to develop product distribution and patient access programs to maximize product... Read more »
Xconomy Insight · Special Report
Download our latest startup e-book today for a deep dive into the biotech world during these unprecedented times. Notably, the trend toward digital and virtual that had already begun has been... Read more »
From Our Editors · Special Report
The AI, Big Data, and R&D Boom
Learn what’s fueling San Francisco’s boom in AI, big data, and R&D, explore promising investment and partnership opportunities, and align the latest trends and... Read more »
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound’s Disease Impact
While you missed the live webinar, you can still watch a recording by following the link below.
... Read more »
From Our Editors · Podcast
The AI, Big Data, and R&D Boom
Learn what’s fueling San Francisco’s boom in AI, big data, and R&D; explore promising investment and partnership opportunities, and align the latest trends and... Read more »
From Our Editors · Special Report
Becoming the Cell & Gene Therapy Hub
Learn what’s fueling Philadelphia’s growing cell and gene therapy ecosystem, explore promising investment and partnership opportunities, and align the latest trends and technologies with... Read more »
From Our Editors · Podcast
Becoming the Cell & Gene Therapy Hub
Learn what’s fueling Philadelphia’s growing cell and gene therapy ecosystem, explore promising investment and partnership opportunities, and align the latest trends and technologies with... Read more »
Sponsored · Webinar
The Next Dimension of Precision Medicine?
While you missed the live webinar, you can still watch a recording by following the link below.
E3 ligases... Read more »
From Our Editors · Special Report
Biopharma’s Future in Digital Health
Learn what’s fueling Boston’s biotech investment and partnership opportunities by reading our special report packaging the highlights from the recent Xcelerating Life Sciences Boston event.
Sponsored · Video
Xcelerating Life Sciences Fireside Chat
Joe Panetta, president and CEO of Biocom, speaks with Xconomy Managing Editor Dan Stanton about the Bay Area’s special place in the life... Read more »
Sponsored · Video
Xcelerating Life Sciences Fireside Chat
Teresa Lavoie, principal at Fish & Richardson, speaks with Xconomy Managing Editor Dan Stanton about the legal complications of using machine learning and... Read more »
From Our Editors · Special Report
Even during the most difficult of times, the life science sector continues to push forward with innovation. The recent rapid progression of drug development, diagnostic tests, and healthcare tools has propelled... Read more »
Sponsored · Webinar
While you missed the live webinar, you can still watch a recording by following the link below.
The presentation will provide an understanding why manufacturing execution systems (MES) should be considered... Read more »
From Our Editors · Podcast
Learn what’s fueling Boston’s biotech investment and partnership opportunities by listening to our podcast packaging the highlights from the recent Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health event. Hosted... Read more »
Sponsored · Video
Xcelerating Life Sciences Fireside Chat
David Horton, director of Regulatory Affairs at Medpace, sits down with Xconomy Managing Editor Dan Stanton to discuss the importance of early planning... Read more »
Sponsored · Webinar
While you missed the live webinar, you can still watch a recording by following the link below.
The presentation will provide an overview of the evolving regenerative medicine supply chain and... Read more »
Sponsored · Webinar
While you missed the live webinar, you can still watch a recording by following the link below.
Simple Signaling Reporter Assays – Easily Quantify Activation & Inhibition of Cellular Pathways
Cell-based... Read more »
Sponsored · Webinar
While you missed the live webinar, you can still watch a recording by following the link below.
Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury (DILI) Early in Drug... Read more »
From Our Editors · Special Report
Learn what’s fueling San Diego’s biotech investment and partnership opportunities by downloading our special report packaging the highlights from the recent Xcelerating Life Sciences San Diego: Biomedical Breakthroughs in Precision Medicine... Read more »
Sponsored · Whitepaper
Emerging biotechs are a force to be reckoned with. In 2018, approximately 70% of clinical pipelines belonged to emerging biotechs, who were also responsible for nearly 64% of new active substances... Read more »
From Our Editors · Podcast
Learn what’s fueling San Diego’s biotech investment and partnership opportunities by listening to our podcast packaging the highlights from the recent Xcelerating Life Sciences San Diego: Biomedical Breakthroughs in Precision Medicine... Read more »
Sponsored · Whitepaper
The existing framework around modern clinical trials is antiquated and inefficient. The foundations for clinical development date back to the 1938 US Food, Drug, and Cosmetic Act which gave the FDA... Read more »
Sponsored · Special Report
The story of the “canary in the coal mine” is an advanced warning of danger. The metaphor originates from when miners used to carry caged canaries while at work; if the... Read more »
Sponsored · Video
Dong-Hoon Jin, Founder and CEO of WellMarker Bio Co., Ltd (WMBIO), speaks at BIO-Europe 2019 in Hamburg about their programs focused on predictive biomarker-based anticancer drugs to identity novel targets. WMBIO... Read more »
Sponsored · Whitepaper
This white paper is designed to demonstrate the utility of using the MarketScan® Inpatient View and Outpatient View (now known as IBM® MarketScan® Inpatient View and Outpatient View) online tools to... Read more »
Sponsored · Whitepaper
Over the past several years, the pharmaceutical industry has witnessed significant growth in the biologics sector, with biologics representing more than $150 billion in global sales in 2013. By 2020 they... Read more »
Sponsored · Video
Akseli Hemminki, Founder, CEO, and Chairman of the Board of TILT Biotherapeutics, discusses how TILT is different from other immune-therapy companies. Their approach is based on human observations during trials, for... Read more »
Sponsored · Video
Lawrence Lamb, Executive VP and Chief Scientific Officer at Incysus Therapeutics, tells an inspirational story about the impetus behind the immuno-oncology company’s formation to advance a unique and innovative approach to... Read more »
Sponsored · Whitepaper
One of the biggest challenges for life sciences companies is finding sources of funding to keep research and development moving forward. In this guide, we’ll explore the different sources of funding... Read more »
Sponsored · Video
PRA Health Sciences executives Sol Babani, Senior VP for Drug Development and Scott Schliebner, Senior VP for the Center for Rare Diseases and Digital Therapeutics, spoke at Biotech Showcase 2020 about... Read more »
Sponsored · Whitepaper
Brain and neurological disorders are among the toughest conditions to diagnose and treat, but new approaches and technologies are on the horizon that could change how researchers and clinicians approach them.... Read more »
Sponsored · Video
Fidelta’s Managing Director, Adrijana Vinter, speaks at BIO-Europe® 2019 in Hamburg about her company’s excellence in integrated drug discovery services, from target validation to early preclinical development. The CRO is able... Read more »
Sponsored · Whitepaper
The Issue: Approved biological products are required to be accompanied by analytical tests to demonstrate safety, purity, and potency that are validated and performed under current Good Manufacturing Processes (cGMP)... Read more »
Sponsored · Video
Synthego’s Brian Schneider, Territory Account Manager, chats with Xconomy Publisher Brian Caine just before the company presented the “Young Innovator” award at the 2019 Xconomy Awards Boston. He explains the company’s aim... Read more »
Sponsored · Video
Dr. Louis Boon is Chief Scientific Officer of Bioceros, based in the Netherlands, a division of Poland’s Polpharma Biologics Group, a one-stop-shop CDMO offering novel technologies on their own platform generating... Read more »
Sponsored · Video
Marco Cerato, Senior VP of Business Development and Strategic Partnerships at Mundipharma, speaks at BIO-Europe® 2019 in Hamburg about how his company’s successes in the market are resulting from a shift... Read more »
Sponsored · Video
Jeff Daelman, Business Development Manager at Rousselot Biomedical, speaks at BIO-Europe® 2019 in Hamburg about X-Pure®, an innovative range of purified gelatins and collagens designed explicitly for (bio)medical applications and backed... Read more »
Sponsored · Video
PharmAbcine’s CEO, Dr. Jin-San Yoo, speaks at BIO-Europe 2019 in Hamburg about the South Korean clinical stage immune-oncology company’s several successful and upcoming clinical trials in Melbourne, Australia, and elsewhere. PharmAbcine... Read more »
Sponsored · Video
Co-founders of Rgenix, CEO Masoud Tavazoie and COO David Darst, speak at BIO-Europe® 2019 in Hamburg about their clinical-stage cancer therapeutics company that focuses on the RNA space to identify novel... Read more »
Sponsored · Video
Jigar Patel, CEO of Nimble Therapeutics, speaks at BIO-Europe® 2019 in Hamburg about the spin-out last April of Nimble from Roche to accelerate the development and discovery of peptide-based therapeutics, and... Read more »
Sponsored · Whitepaper
The actual pitch deck you use when pitching biotech investors probably won’t matter quite as much as the delivery of your fundraising pitch. Still, creating that deck is a critical part... Read more »
Sponsored · Video
Hahn-Jun Lee, President and CEO of Polaryx Therapeutics Inc., speaks at BIO-Europe® 2019 in Hamburg about how the company accelerates the availability of treatment options for underserved patients, and what the... Read more »
Xconomy Insight · Webinar
While you missed the live webinar, you can still watch a recording by following the link below.
Wednesday, Nov.... Read more »
Sponsored · Video
Hours before presenting the “Secret Weapon” award at the 2019 Xconomy Awards Boston, BREX’s Matt Henkel, Manager of Business Development and GTM Lead, chatted with Brian Caine, Xconomy’s Publisher. They... Read more »
Xconomy Insight · Webinar
While you missed the live webinar, you can still watch a recording by following the link below.
Potential cures... Read more »
From Our Partners · Webinar
While you missed the live webinar, you can still watch a recording by following the link below.
Prepare for... Read more »
Xconomy Insight · Special Report
This guide goes deeper than the last and gathers advice to help entrepreneurs solve some of the toughest—and often unexpected—challenges of creating a life sciences startup. Where possible, we also provide... Read more »
Sponsored · Video
Gabriela Apiou, Director of Strategic Alliances at Mass General Research Institute in Boston, explains that the mission of strategic alliances for biomedical research and patient care is the essential retraining of... Read more »
Sponsored · Video
Dr. Irina Staatz-Granzer, Founder and President of Staatz Business Development & Strategy, describes her biotech and pharma consulting company as having two main areas of expertise, business development and market access.... Read more »
Sponsored · Video
Dr. David Giljohann, CEO of Exicure, outlines the company’s unique spherical nucleic acid (SNA™) technology and how this three-dimensional arrangement of nucleic acid will solve the delivery challenge to get into... Read more »
Sponsored · Video
Sofie Vandevyver, Head of Business Operations and Marketing at Barc Lab, highlights the lab’s goal to help every unique client find the right therapy for the right patient within the... Read more »
Sponsored · Video
Tools4Patient was founded by a group of industry veterans of clinical trials to accelerate the launch of drugs to patients by developing predictive algorithms to focus on the detrimental placebo response... Read more »
Sponsored · Video
Sofie Vandevyver, Head of Business Operations and Marketing at Barc Lab, highlights the lab’s goal to help every unique client find the right therapy for the right patient within the... Read more »
Sponsored · Video
Life Biosciences is the world’s leader in longevity research addressing age-related decline. During BIO-Europe, Sree Kant, Head of Business Development at Life Biosciences, talked with Dr. Cora Kaiser about the company’s... Read more »
From Our Partners · Special Report
Download this exclusive profile of Bob Langer—one of 13 Institute Professors at MIT—which features his advice for obtaining funds to get promising technologies from lab to clinic, and where he sees... Read more »
From Our Partners · Whitepaper
Download from our partner, KNect365 Life Sciences
It is an exciting time to be involved in the cell and gene therapy industries. There are both opportunities and challenges around analytical testing,... Read more »
Sponsored · Video
PCT TV recently sat down with Dr. MaryAnne Rizk, Global Vice President of Biopharma Partnerships at Oracle, to discuss the biggest challenges facing clinical trials today and how technology can combat... Read more »
Sponsored · Video
PCT TV recently sat down with Willie Muehlhausen, Head of Innovation, ICON to discuss transforming patient trials and patient recruitment. Muehlhausen explored the challenges to patient recruitment in clinical trials and... Read more »
From Our Partners · Video
Cheryl Scott, Senior Scientific Editor, BioProcess International Magazine, recently sat down with Nadine M. Ritter, Ph.D., Global BioTech Experts for an interview on the increasing importance of sound product characterization and... Read more »
From Our Partners · Video
Anne Montgomery, Editor In Chief, BioProcess International Magazine, recently sat down with Kavita Ramalingam Iyer, PH.D., Associate Director, Global Regulatory Affairs and Clinical Safety – CMC Vaccines at Merck Sharp &... Read more »
Sponsored · Video
Brian Caine, Publisher, BioProcess International Magazine, recently sat down with Jarrod Medeiros, Product Manager, IDBS at BioTech Week Boston in September to discuss data management and challenges in the pharmaceutical and... Read more »
Sponsored · Video
Brian Caine, Publisher, BioProcess international Magazine, recently sat down with Jonathan Royce, Business Leader Chromatography Resins, GE Healthcare at BioTech Week Boston in September to discuss market trends impacting Monoclonal antibodies.... Read more »
From Our Editors · Video
Lita Nelsen recently retired as the long-time director of MIT’s Technology Licensing Office. She and Xconomy’s Corie Lok recently sat down for an interview during Biotech Week Boston in September. Nelsen,... Read more »
From Our Editors · Video
David Edwards is a professor at Harvard University. He sat down with Xconomy’s Corie Lok during Biotech Week Boston in September to share his vision for the future of food and... Read more »
From Our Editors · Video
David Berry is a general partner with venture capital firm Flagship Pioneering. In recent years, he has co-founded companies that are developing microbiome products for both human therapeutics and agricultural applications.... Read more »
From Our Editors · Podcast
Christopher Ahlberg, the CEO of Recorded Future, a cybersecurity startup based in Somerville, MA. Recorded Future has an intriguing approach to solving some of the biggest problems in data and network... Read more »
From Our Editors · Podcast
Mary Lou Jepsen is a fearsome samurai when it comes to the design and manufacturing of electronics, especially displays. Her latest venture is Openwater, a San Francisco-based startup that’s using LCDs—the... Read more »
Xconomy Insight · Special Report
An exploration of the science, technologies and trends with potential to radically change how, when and where people receive healthcare
From Our Editors · Special Report
Xconomy presents a two-part series on efforts to transform the Sacramento region into a major new innovation cluster. Part 1 looks at changes in Sacramento that could make the city more... Read more »
From Our Editors · Special Report
Healthcare, agriculture, and manufacturing remain the bread and butter of the private sector in Madison, WI, and the surrounding region, but healthcare IT has arguably become the area’s most buzz-worthy industry.... Read more »
From Our Editors · Special Report
It’s no secret that the Boston area is home to a formidable group of companies related to cybersecurity. Just how big is the local cluster? Xconomy surveyed the landscape and found... Read more »
From Our Editors · Slideshow
A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. The results were... Read more »
From Our Editors · Special Report
For young people today, the view to the future is arguably cloudier than it has been in several generations, thanks to breakneck technological change and increasing economic uncertainty. What kinds of... Read more »
From Our Editors · Special Report
Wade Roush’s three-part exploration of Santa Cruz’s innovation ecosystem, its history of launching successful companies and entrepreneurs, and its efforts to reverse perceptions that it is anti-business.